Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Copelan

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
American Journal of Hematology|January 23, 2016
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutationsBetty Ky Hamilton, Valeria Visconte, Xuefei Jia, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsSergio Giralt, Luciano Costa, Jeffrey Schriber, et al.
Clinical Pharmacology and Therapeutics|September 25, 2019
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell TransplantJai N Patel, Issam S Hamadeh, Myra Robinson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.
Journal of the National Cancer Institute|March 1, 2014
Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiationSudipto Mukherjee, Chandana A Reddy, Jay P Ciezki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2019
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant PatientsIssam S Hamadeh, Qing Zhang, Nury Steuerwald, et al.
British Journal of Haematology|March 4, 2020
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic MicroangiopathyNarendranath Epperla, Ang Li, Brent Logan, et al.
Blood|April 21, 2010
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionDavid I Marks, Tao Wang, Waleska S Pérez, et al.
The Journal of Clinical Investigation|January 27, 2015
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromesYogen Saunthararajah, Mikkael Sekeres, Anjali Advani, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
American Journal of Hematology|January 23, 2016
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutationsBetty Ky Hamilton, Valeria Visconte, Xuefei Jia, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsSergio Giralt, Luciano Costa, Jeffrey Schriber, et al.
Clinical Pharmacology and Therapeutics|September 25, 2019
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell TransplantJai N Patel, Issam S Hamadeh, Myra Robinson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.
Journal of the National Cancer Institute|March 1, 2014
Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiationSudipto Mukherjee, Chandana A Reddy, Jay P Ciezki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2019
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant PatientsIssam S Hamadeh, Qing Zhang, Nury Steuerwald, et al.
British Journal of Haematology|March 4, 2020
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic MicroangiopathyNarendranath Epperla, Ang Li, Brent Logan, et al.
Blood|April 21, 2010
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionDavid I Marks, Tao Wang, Waleska S Pérez, et al.
The Journal of Clinical Investigation|January 27, 2015
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromesYogen Saunthararajah, Mikkael Sekeres, Anjali Advani, et al.
Pageof 9